CompletedPHASE1, PHASE2NCT00186680

CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant

Studying Cerebrotendinous xanthomatosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stanford University
Principal Investigator
Ginna Laport
Stanford University
Intervention
high dose chemo then auto hematopoietic cell transplant(procedure)
Enrollment
99 target
Eligibility
19-70 years · All sexes
Timeline
19962005

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00186680 on ClinicalTrials.gov

Other trials for Cerebrotendinous xanthomatosis

Additional recruiting or active studies for the same condition.

See all trials for Cerebrotendinous xanthomatosis

← Back to all trials